Profil
Mr. Michael Mullette is a Chief Commercial Officer at Vaxcyte, Inc. Mr. Mullette was previously employed as a Chief Executive & Operating Officer by Lykos Therapeutics, Inc. and a Managing Director-Canada by Moderna, Inc. He received his undergraduate degree from Villanova University and an MBA from Lehigh University.
Aktive Positionen von Michael Mullette
| Unternehmen | Position | Beginn |
|---|---|---|
| VAXCYTE, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michael Mullette
| Unternehmen | Position | Ende |
|---|---|---|
Lykos Therapeutics PBC
Lykos Therapeutics PBC BiotechnologyHealth Technology Engages in healing and well-being through psychedelic drug development & therapist training programs | Vorstandsvorsitzender | 01.11.2025 |
| MODERNA, INC. | Corporate Officer/Principal | - |
Ausbildung von Michael Mullette
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Lykos Therapeutics PBC
Lykos Therapeutics PBC BiotechnologyHealth Technology Engages in healing and well-being through psychedelic drug development & therapist training programs | Health Technology |
















